Colorectal cancer (CRC) is the third most common and second most lethal cancer in the world. In most countries, including Russia, the number of new cases of CRC continues to grow and may reach 2.2 million by 2030. The favorable prognosis when starting treatment for the disease in the early stages is very high, which makes screening programs for CRC cost-effective. Since 2020, a new laboratory research method has been actively introduced in Russia: the determination of human hemoglobin and transferrin in feces, which makes it possible to diagnose diseases of the gastrointestinal tract. Quantitative determination of human hemoglobin and transferrin in feces is carried out to detect gastrointestinal bleeding of any etiology. Based on the concentration of the determined substances and their ratio, this test allows you to identify intestinal polyps and various forms of colorectal cancer, as well as clearly determine the need for colonoscopy for each specific patient. Diagnostic colonoscopy is performed for the purpose of screening (that is, examining the patient before complaints appear), malignant neoplasms, or precancerous diseases of the colon. During the study, the frequency of detection of adenomas, polyps, and colorectal cancer was assessed. Statistical processing of the data obtained consisted of statistical observation of the results of a stool test for occult blood exceeding the reference value (50 ng/ml or more). Automatic analyzers are highly sensitive, making it possible to diagnose the disease already at the initial stages of the disease. Also in 2020, the oncology service of Bashkortostan switched to a new analytical two-marker system. If hemoglobin is present, we can talk about a problem in the lower parts of the intestine, but if transferrin is present, we can talk about a higher-lying tumor.
Read full abstract